Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Review Articles

Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside: Hyun-Jung Kim, Charles L. Edelstein; Kidney Res Clin Pract. 2012;31(3):132-138. Published online August 10, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.07.002
Cited By 16; Full text PubReader PDF

A Case of Kaposi's Sarcoma Improved by Sirolimus Treatment in the Kidney Transplant Recipient: Seung Min Lee, M.D. So Yeon Park, M.D. Soo Jin Kim, M.D. Young Soo Song, M.D. Heon Ho Song, M.D. Samuel Lee, M.D. Eun Sook Nam, M.D. and Jieun Oh, M.D.; Korean J Nephrol. 2009;28(1):82-87.; PDF

A Case of Interstitial Pneumonitis Associated withSirolimus Treatment in Renal Transplantation Recipient: Ji Young Lee, M.D., Sun Young Kim, M.D., Seung Woon Byun, M.D., Young Sun Yeo, M.D., Jai Won Chang, M.D., Won Seok Yang, M.D., Soon Bae Kim, M.D., Jung Sik Park, M.D. and Su-Kil Park, M.D.; Korean J Nephrol. 2008;27(5):611-615.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

15,127	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
20,036	C4d Puzzle in ABO-incompatible kidney transplantation
8,640	How should we treat acute kidney injury caused by renal congestion?
35,516	Uremic pruritus: pathophysiology, clinical presentation, and treatments
13,281	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.